FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved Mylan Institutional LLC's original application for a generic docetaxel anhydrous product (ANDA208859).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer
• Urothelial Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

ORIG AP for DOCETAXEL (DOCETAXEL ANHYDROUS)